Isocell

Laboratoires Isocell is a French life sciences company specializing in the study of oxidative stress and the development of antioxidant-based therapies and supplements. Founded in 1995, the company is best known for its proprietary GliSODin technology, which represents the first orally effective form of Superoxide Dismutase (SOD) combined with a wheat protein (gliadin) to ensure bioavailability. Isocell focuses on dermatological and systemic health applications, including the treatment of vitiligo, skin aging, and UV-induced damage. The company operates globally, providing both finished products and patented ingredients for the pharmaceutical, cosmetic, and nutraceutical industries.